logo
  Join        Login             Stock Quote

Fortune 500 Healthcare Products Company Selects NextDocs to Manage Document Compliance

Thursday, June 13, 2013 10:34 AM


Fortune 500 Healthcare Products Company Selects NextDocs to Manage Document Compliance

CONSHOHOCKEN, Pa., June 13, 2013 /PRNewswire/ -- NextDocs announced today that it has signed its largest and most comprehensive contract to date for its regulated content management and compliance software suite.  The contract is with a leading Fortune 500 consumer healthcare products company with more than $1.5 billion in revenue. 

The Fortune 500 company selected NextDocs as its strategic platform for managing regulated document management and compliance across its global organization, replacing its legacy Documentum platform.  The company will utilize the NextDocs suite to manage the creation, approval, storage and retrieval of critical compliance documents.

NextDocs solutions, which work alongside Microsoft's SharePoint platform, enable businesses in regulated industries to comply with FDA and other regulatory agencies, while also streamlining and automating business processes, improving collaboration and reducing costs.

"NextDocs has earned its reputation by helping more than 100 life sciences and healthcare companies improve their compliance and efficiency – and thus enabling them to bring treatments to market faster, cheaper and with higher quality," said John Loucks, vice president, global sales and alliances at NextDocs.

NextDocs customers include Astra Zeneca, McKesson, Sandoz, Sanofi and the National Cancer Center in Japan.  For more information on NextDocs, visit www.nextdocs.com.

CONTACT:  Dan Cahill, 917.617.0106, dcahill@roaringpr.com

SOURCE NextDocs

(Source: PR Newswire )
(Source: Quotemedia)

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.